Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies-Reference-Cited by-同舟云学术

Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies

Published:2007-11 Issue:11 Volume:82 Page:1371-1380
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Wish Jay B.,Coyne Daniel W.

Publisher

Elsevier BV

Subject

General Medicine

Reference65 articles.

1. The prevalence of anemia in patients with chronic kidney disease;McClellan;Curr Med Res Opin,2004

2. Kidney Early Evaluation Program;National Kidney Foundation;Am J Kidney Dis,2005

3. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease;National Kidney Foundation;Am J Kidney Dis,2006

4. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target;National Kidney Foundation;Am J Kidney Dis,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Imatinib treatment on renal anaemia in chronic myeloid leukemia patients;Journal of Oncology Pharmacy Practice;2023-03-02

2. An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects;Kidney International Reports;2018-07

3. Iron-deficiency Anemia and Chronic Kidney Disease: An Overview;World Journal of Anemia;2018

4. Changing the paradigms for the treatment of chronic kidney disease;Kidney International Supplements;2017-12

5. Delayed Hypersensitivity with Ferric Carboxymaltose;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2017